D.E. Shaw & Co’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-542,638
| Closed | -$25.1M | – | 4165 |
|
|
2019
Q2 | $25.1M | Buy |
542,638
+461,244
| +567% | +$13M | 0.03% | 643 |
|
|
2019
Q1 | $1.98M | Buy |
81,394
+64,794
| +390% | +$1.35M | ﹤0.01% | 2164 |
|
|
2018
Q4 | $237K | Sell |
16,600
-20,043
| -55% | -$304K | ﹤0.01% | 3469 |
|
|
2018
Q3 | $557K | Buy |
+36,643
| New | +$562K | ﹤0.01% | 3046 |
|
|
2018
Q2 | – | Sell |
-14,218
| Closed | -$232K | – | 3985 |
|
|
2018
Q1 | $232K | Sell |
14,218
-222,218
| -94% | -$3.56M | ﹤0.01% | 3262 |
|
|
2017
Q4 | $3.03M | Buy |
236,436
+71,503
| +43% | +$813K | ﹤0.01% | 1844 |
|
|
2017
Q3 | $2.03M | Buy |
+164,933
| New | +$1.53M | ﹤0.01% | 2008 |
|
|
2017
Q2 | – | Sell |
-15,209
| Closed | -$136K | – | 3631 |
|
|
2017
Q1 | $136K | Buy |
+15,209
| New | +$162K | ﹤0.01% | 3172 |
|
|
2016
Q4 | – | Sell |
-20,681
| Closed | -$140K | – | 3696 |
|
|
2016
Q3 | $140K | Buy |
+20,681
| New | +$80K | ﹤0.01% | 3251 |
|
|
2016
Q2 | – | Sell |
-15,428
| Closed | -$46K | – | 3628 |
|
|
2016
Q1 | $46K | Sell |
15,428
-13,334
| -46% | -$40K | ﹤0.01% | 3338 |
|
|
2015
Q4 | $121K | Buy |
28,762
+1,603
| +6% | +$7.32K | ﹤0.01% | 3653 |
|
|
2015
Q3 | $124K | Buy |
+27,159
| New | +$161K | ﹤0.01% | 3587 |
|
|
2015
Q2 | – | Sell |
-41,750
| Closed | -$308K | – | 3958 |
|
|
2015
Q1 | $308K | Sell |
41,750
-313,319
| -88% | -$2.23M | ﹤0.01% | 3285 |
|
|
2014
Q4 | $1.68M | Buy |
+355,069
| New | +$1.4M | ﹤0.01% | 2414 |
|
|
2014
Q1 | – | Sell |
-37,935
| Closed | -$190K | – | 4792 |
|
|
2013
Q4 | $190K | Sell |
37,935
-30,531
| -45% | -$166K | ﹤0.01% | 4281 |
|
|
2013
Q3 | $426K | Sell |
68,466
-466,617
| -87% | -$2.77M | ﹤0.01% | 3688 |
|
|
2013
Q2 | $2.43M | Buy |
+535,083
| New | +$2.88M | ﹤0.01% | 1938 |
|